Patient-reported outcomes with the use of elranatamab in the MagnetisMM-3 trial VJHemOnc – Video Journal of Hematology & HemOnc 3:27 1 year ago 348 Далее Скачать
MagnetisMM-3: elranatamab in R/R multiple myeloma naive to BCMA-directed therapy VJHemOnc – Video Journal of Hematology & HemOnc 6:07 1 year ago 448 Далее Скачать
Dr Mohty on the Real-World Efficacy of Elranatamab in R/R Multiple Myeloma OncLive 2:00 5 months ago 95 Далее Скачать
Evaluating the safety and efficacy of elranatamab in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:17 1 year ago 266 Далее Скачать
Elranatamab: Extended Follow-up & Biweekly Admin for RRMM | MagnetisMM-3 Study | ASCO 2023 International Myeloma Foundation 6:54 1 year ago 705 Далее Скачать
What Does MagentisMM-3 Data Tell Us About Elranatamab? Blood Cancers Today 9:44 1 year ago 160 Далее Скачать
Impact of prior BCMA-directed therapy on the efficacy of elranatamab in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:52 1 year ago 111 Далее Скачать
Efficacy and Safety of Elranatamab in Pts with Relapsed/Refractory Multiple Myeloma: MagnetisMM-3 International Myeloma Foundation 9:14 1 year ago 769 Далее Скачать
Elranatamab Induces Durable Responses for Patients with Relapsed or Refractory Multiple Myeloma International Myeloma Foundation 7:00 1 year ago 954 Далее Скачать
Understanding Electronic Patient-Reported Outcomes (ePRO) in Clinical Trials GCP-Mindset - All About Clinical Research 6:02 5 months ago 649 Далее Скачать
MagnetisMM-3: elranatamab in relapsed/refractory multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 10:39 2 years ago 550 Далее Скачать
Elranatamab in Combination with Daratumumab for Pts with RRMM: Phase 3 MagnetisMM-5 International Myeloma Foundation 9:07 1 year ago 546 Далее Скачать
Safety and efficacy of elranatamab in RRMM & prior BCMA therapies: Analysis from MagnetisMM studies International Myeloma Foundation 7:04 1 year ago 237 Далее Скачать
MagnetisMM-3: elranatamab for myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:16 3 years ago 499 Далее Скачать
MagnestisMM-1: elranatamab alone or with immunomodulatory agents in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:47 2 years ago 103 Далее Скачать
MagnetisMM-3 extended follow up results: elranatamab monotherapy in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 5:49 1 year ago 370 Далее Скачать
Positive Correlation in Patient-Reported Outcomes in Phase III ENLIVEN Trial Targeted Oncology 1:10 5 years ago 284 Далее Скачать
Positive Correlation With Patient-Reported Outcomes Seen in Phase III ENLIVEN Trial Targeted Oncology 1:10 5 years ago 64 Далее Скачать
Elranatamab - Upcoming Myeloma Therapy HealthTree University for Multiple Myeloma 15:43 1 year ago 1 312 Далее Скачать
